Britton, WJ; Lockwood, DNJ; (2004) Leprosy. Lancet, 363 (9416). p. 1209. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(04)15952-7

Full text not available from this repository. (Request a copy)


Leprosy remains an important health problem worldwide. The disease is caused by a chronic granulomatous infection of the skin and peripheral nerves with Mycobacterium leprae. The clinical range from tuberculoid to lepromatous leprosy is a result of variation in the cellular immune response to the mycobacterium. The resulting impairment of nerve function causes the disabilities associated with leprosy. This review summarises recent advances in understanding of the biology of leprosy, clinical features of the disease, the current diagnostic criteria, and the new approaches to treatment of the infection and the immune-mediated complications. Supervised multi-drug therapy (MDT) for fixed durations is highly effective for all forms of the disease. The widespread implementation of MDT has been associated with a fall in the prevalence of the leprosy but as yet no reduction in the case- detection rate globally. Thus, leprosy control activities must be maintained for decades to Interrupt transmission of infection.

Item Type: Article
Keywords: Necrosis-factor-alpha, human-immunodeficiency-virus, nerve-, function impairment, hla-class-ii, erythema-nodosum leprosum, phenolic glycolipid-i, t-cell responses, mouse foot pad, mycobacterium-leprae, lepromatous leprosy
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
PubMed ID: 15081655
Web of Science ID: 220748100022
URI: http://researchonline.lshtm.ac.uk/id/eprint/14836


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item